FDA.reportPublic FDA data

entrectinib 50 MG Oral Pellet

RxCUI
2668595
RxNorm name
entrectinib 50 MG Oral Pellet
Display name
entrectinib 50 MG Oral Pellet
Full name
entrectinib 50 MG Oral Pellet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:20

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
c7c71b0c-2549-4495-86b6-c2807fa54908entrectinib 50 MG Oral Pellet [PSN] · entrectinib 50 MG Oral Pellet [SCD]218These highlights do not include all the information needed to use ROZLYTREK ® safely and effectively. See full prescribing information for ROZLYTREK. ROZLYTREK ® (entrectinib) capsules, for oral use ROZLYTREK ® (entrectinib) oral pellets Initial U.S. Approval: 201920251204